Ipca Labs approves acquisition of 26.5% stake in Lyka Labs - Livemint
Shares of Ipca Labs were trading 1% lower at ?2037.80 while Lyka were locked in 5% upper circuit as compared to a 0.5% gain in Nifty pharma index.
The board of Ipca Labs has approved the acquisition of 26.574% of the paid-up share capital of Lyka Labs Limited and entering into a joint management control agreement with the promoters of Lyka Labs… [+1606 chars]
Read More
Other Stories in Business
- Senco Gold QIP Opens To Raise Rs 500 Crore
- Brokerage Views: Goldman Sachs On DMart, Morgan Stanley On Zomato, CLSA On Cement Industry And More
- Correction In RIL, Tata Motors Led To Sharp Spike In Their Futures Open Interest
- Indian Capital Market - A Golden Era: Motilal Oswal
- Swiggy Growth Headroom, Profitability Prompt 'Outperform' Rating From CLSA On Initiation
- Intra-Cellular Therapies (ITCI): Parkinson's Disease Drug Expansion Could Be The Next Move
- Juan Soto’s $765M deal with the Mets is the largest in MLB history. Here’s who he passed
- Trump nominates ex-ambassador to Mexico to serve as deputy secretary of State
- Complete Berachain Airdrop Guide: Get Free Tokens
